RBF Capital LLC lessened its position in KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 34.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 521,319 shares of the company's stock after selling 277,131 shares during the period. RBF Capital LLC owned about 1.14% of KORU Medical Systems worth $1,423,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the company. Aaron Wealth Advisors LLC purchased a new stake in KORU Medical Systems during the 2nd quarter worth $28,000. Allspring Global Investments Holdings LLC acquired a new position in KORU Medical Systems during the 2nd quarter worth approximately $28,000. Legato Capital Management LLC acquired a new stake in KORU Medical Systems in the second quarter valued at approximately $35,000. Virtu Financial LLC purchased a new stake in shares of KORU Medical Systems during the first quarter valued at approximately $63,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of KORU Medical Systems during the second quarter worth $107,000. Hedge funds and other institutional investors own 58.60% of the company's stock.
KORU Medical Systems Stock Performance
NASDAQ KRMD traded down $0.28 on Thursday, hitting $3.67. The stock had a trading volume of 42,197 shares, compared to its average volume of 111,408. The company's 50-day moving average is $2.97 and its two-hundred day moving average is $2.61. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock has a market cap of $168.23 million, a price-to-earnings ratio of -14.72 and a beta of 0.48. KORU Medical Systems, Inc. has a one year low of $1.98 and a one year high of $4.20.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on KRMD. Craig Hallum raised their price objective on KORU Medical Systems from $4.00 to $5.00 and gave the stock a "buy" rating in a research note on Thursday, November 14th. Canaccord Genuity Group raised their price target on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Finally, Piper Sandler boosted their price objective on shares of KORU Medical Systems from $3.00 to $3.50 and gave the company an "overweight" rating in a research report on Thursday, November 14th.
Get Our Latest Report on KORU Medical Systems
KORU Medical Systems Company Profile
(
Free Report)
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Further Reading
Before you consider KORU Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.
While KORU Medical Systems currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
